Health technology company Seqster announced Thursday the launch of its new 1-Click Sites platform, tapping BioIVT as its ...
Verismo Therapeutics, a clinical-stage CAR T cell therapy company pioneering a novel multichain KIR-CAR platform technology, ...
An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical ...
Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the presentation of updated data from its Phase 1 trial of ...
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...
SEQSTER Enters Partnership with BioIVT to Expand Access to High-Quality Clinical and Biological Data Clinical research ...
Clinical site selection platform RyghtAI has launched a search engine designed to give drug developers and contract research ...
Second candidate from Tenvie’s product engine to enter clinical development Phase 1 first-in-human study to evaluate single and multiple ascending doses of TNV108 in healthy volunteers Preliminary ...
FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall ...
In this episode of The OncoloGIST, Dr Christine Bestvina of UChicago Medicine provides a comprehensive look at the rapidly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results